American Society for Experimental Neurotherapeutics (ASENT) 20th Annual Meeting

Michela Gallagher will present “Targeting hippocampal overactivity in prodromal Alzheimer’s disease” in the Alzheimer’s Emerging Therapies session, on March 9 at 1:00 pm.

2018 NIH Alzheimer’s Research Summit

Michela Gallagher will participate in a session on “Emerging Therapeutics” to discuss AgeneBio’s Programs targeting hippocampal hyperactivity in the Mild Cognitive Impairment phase of prodromal Alzheimer’s disease.